MedTrace Logo

The Effect of Sequential Therapy on Alzheimer's Disease

NCT07768579 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2026-08-19

No results posted yet for this study

Summary

The goal of this observational study is to learn how Alzheimer's disease changes over time in people at different stages of the disease. It will look at changes in memory and thinking, daily activities, behavior, and traditional Chinese medicine symptom patterns. It will also learn about the outcomes and safety of sequential traditional Chinese medicine treatment based on the stage of Alzheimer's disease. The main questions this study aims to answer are:

* How do memory and thinking, daily activities, behavior, and traditional Chinese medicine symptom patterns naturally change over time in participants with early-, middle-, and late-stage Alzheimer's disease?
* How do symptoms and traditional Chinese medicine symptom patterns change together as Alzheimer's disease progresses?
* Do participants receiving stage-based sequential traditional Chinese medicine treatment have different changes in memory and thinking, daily activities, behavior, and overall disease status?
* What medical problems or side effects occur during sequential traditional Chinese medicine treatment?

About 600 participants aged 55 to 85 years will take part in this study. Participants will be followed for 12 months.

Participants will:

* Visit the study center at the start of the study and at 3, 6, 9, and 12 months.
* Complete assessments of memory and thinking, daily activities, behavior, overall disease status, and traditional Chinese medicine symptoms.
* Have blood tests and other study examinations.
* Have their treatment use and medical problems recorded during follow-up.

Conditions

Sponsors & Collaborators

  • Dongzhimen Hospital, Beijing

    lead OTHER

Principal Investigators

  • JinZhou Tian · Dongzhimen Hospital, Beijing

Eligibility

Min Age
55 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-04-30
Primary Completion
2028-12-31
Completion
2028-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07768579 on ClinicalTrials.gov